Mark G. Pedretti

Partner

Mark is a senior transactional partner who serves as the Global Chair of Reed Smith's Private Equity Group. He focuses on private equity, mergers and acquisitions, and fund formation.

Recognitions

  • Ranked as a Leading Partner in Legal 500 USA for Private Equity Buyouts: Middle-Market (up to $500m), 2020-2026. Methodology displayed on legal500.com.*

  • Ranked in Legal 500 USA, Corporate - Leading Partner, 2025; Methodology displayed on legal500.com.*

  • Selected for inclusion in New York Metro Super Lawyers list for Mergers & Acquisitions, 2011, 2014-2019, 2022-2023. Methodology displayed on www.superlawyers.com.*

Credentials

Education

  • St. John's University School of Law, 1992, J.D., cum laude
  • Georgetown University, 1988, B.S.F.S., School of Foreign Service

Professional admissions & qualifications

  • New York
  • New Jersey
  • District of Columbia

Professional affiliations

  • Co-Founder, The Lifelong Water Project, Inc.
  • Director, Ghana-American Community Development, Inc.
  • Advisory Board Member, Centurion Intelligence Partners
  • Advisory Board Member. Niya Partners
  • Advisory Board Member, Saigon Asset Management
  • Advisory Board Member, Tradeteq

News

1 / 19

Events

In The News

  • 30 January 2023 “Reed Smith represents Leeds Equity Partners and portfolio company Exterro on acquisition of Zapproved”
  • 5 January 2023 “Reed Smith advises Leeds Equity Partners on acquisition of e.Republic platform”
  • 1 December 2022 “Reed Smith represents Leeds Equity Partners’ Exterro Inc. in $1B+ recapitalization”
  • 22 September 2021 “Reed Smith NY PE Team Closes Archive360 Platform Acquisition for Leeds Equity Partners”
  • 21 September 2021 “New York-based PE team represents GHO Capital Partners portfolio company Velocity Clinical Research in its add-on acquisition of NRI Clinical Research”
  • 24 June 2021 “Reed Smith represents Leeds Equity Partners in ins platform acquisition of software company Genius SIS”
  • 10 June 2021 “Reed Smith’s industry specific strengths highlighted in Legal 500 USA rankings”
  • 17 July 2020 “Reed Smith hosts inaugural life sciences deal making virtual roundtable with key industry deal makers”
  • 8 July 2020 “Reed Smith represents EW Healthcare Partners in $90 million POP investment in MiMedx Group, Inc. (MDXG: OTC US)"
  • 29 June 2020 “Reed Smith shows wide ranging influence in Legal 500 USA rankings”
  • 14 May 2020 “Reed Smith advises GHO Capital and Fair Journey Biologics on the Combination of FairJourney Biologics with Iontas Limited"
  • 13 May 2020 "Reed Smith represents Venue Concept Inc. (NASDAQ: VERO) on $22.25 Million equity financing"
  • 12 February 2020 "Reed Smith Advises GHO Capital on its investment in FairJourney Biologics"
  • 15 November 2019 "Reed Smith advises Venus Concept Ltd in Merger with Restoration Robotics"
  • 14 November 2019 “EW Healthcare Partners’ Investment in Cognate BioServices” Global Legal Chronicle
  • 7 November 2019 “Venus Concept Completes Merger With Restoration Robotics and Combined Company Raises $28 Million in Private Placement” Globe Newswire
  • 12 June 2019 “Leeds-backed Exterro buys Jordan Lawrence Group” PE HUB
  • 15 March 2019 "Restoration Robotics and Venus Concept Announce Merger to Create a Leading Global Medical Aesthetics Company" Globe Newswire

Representative Clients

Private Funds

  • AEA Investors
  • Apollo Management
  • Blackstone Group
  • CITIC Group
  • Coller Capital
  • California Technology Ventures
  • EW Healthcare Partners
  • GFH Financial Group
  • GHO Capital
  • Gulf Islamic Investments
  • Investcorp International
  • Leeds Equity Partners
  • Marathon Asset Management
  • Nakheel PJSC
  • Neo Capital
  • Niya Partners
  • Rakiza Infrastructure Fund
  • Saigon Asset Management
  • SEDCO Capital
Financial Services
  • Alliant Insurance Services, Inc.
  • American Express
  • BlackRock
  • The Islamic Corporation for the Development of the Private Sector (ICD)
  • JPMorgan Chase
  • MUFG Bank
  • Sumitomo Corporation of America
  • US Trust

Life Sciences and Healthcare

  • Bioventus
  • Centessa Pharmaceuticals
  • Covis Pharma
  • DJO Global
  • FairJourney Biologics
  • MiMedx Group
  • Velocity Clinical Research
  • Venus Concept